AKT1 and urinary bladder cancer: In a separate study, Wang et al. [38] discovered that the E3 ubiquitin ligase RNF126 facilitated the advancement of bladder cancer by boosting the degradation of PTEN, hence activating the EGFR/PI3K/AKT signaling pathway.